Geok Choo Sim

854 total citations
11 papers, 693 citations indexed

About

Geok Choo Sim is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Geok Choo Sim has authored 11 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Geok Choo Sim's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). Geok Choo Sim is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). Geok Choo Sim collaborates with scholars based in United States, Germany and Qatar. Geok Choo Sim's co-authors include Laszlo Radvanyi, Lei Jin, Patrick Hwu, Sheng Wu, Luis M. Vence, Natalia Martín‐Orozco, Yi‐Jun Wang, Deborah A. Sanders, Marc Zapatka and Alexander Steinle and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Geok Choo Sim

11 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geok Choo Sim United States	9	496	423	108	65	38	11	693
Max Klapholz United States	7	515 1.0×	501 1.2×	180 1.7×	52 0.8×	25 0.7×	10	793
Andreas Bonertz Germany	12	599 1.2×	443 1.0×	163 1.5×	44 0.7×	31 0.8×	24	883
Jeanne Galaine France	12	303 0.6×	298 0.7×	158 1.5×	51 0.8×	22 0.6×	28	512
Dmitrij Ostroumov Germany	5	294 0.6×	337 0.8×	137 1.3×	60 0.9×	16 0.4×	6	526
Hayrettin Guvén Sweden	13	358 0.7×	329 0.8×	195 1.8×	33 0.5×	59 1.6×	17	654
Ashwat Nagarajan United States	3	313 0.6×	335 0.8×	178 1.6×	68 1.0×	21 0.6×	4	620
Janina Dörr Germany	2	263 0.5×	253 0.6×	177 1.6×	49 0.8×	32 0.8×	2	530
Hassan Sadozai Canada	10	233 0.5×	230 0.5×	101 0.9×	61 0.9×	21 0.6×	15	422
Eveline M. Dijkgraaf Netherlands	5	406 0.8×	291 0.7×	149 1.4×	31 0.5×	23 0.6×	5	585
Derrick Callahan United States	6	435 0.9×	238 0.6×	127 1.2×	31 0.5×	24 0.6×	7	584

Countries citing papers authored by Geok Choo Sim

Since Specialization

Citations

This map shows the geographic impact of Geok Choo Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geok Choo Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geok Choo Sim more than expected).

Fields of papers citing papers by Geok Choo Sim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geok Choo Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geok Choo Sim. The network helps show where Geok Choo Sim may publish in the future.

Co-authorship network of co-authors of Geok Choo Sim

This figure shows the co-authorship network connecting the top 25 collaborators of Geok Choo Sim. A scholar is included among the top collaborators of Geok Choo Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geok Choo Sim. Geok Choo Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Alimzhanov, Marat, Patricia Soulard, Astrid Zimmermann, et al.. (2019). Abstract 2269: ATR inhibitor M6620 enhances anti-tumor efficacy of the combination of the anti-PD-L1 antibody avelumab with platinum-based chemotherapy. Immunology. 2269–2269. 2 indexed citations

2.

Alimzhanov, Marat, Patricia Soulard, Astrid Zimmermann, et al.. (2019). Abstract 2269: ATR inhibitor M6620 enhances anti-tumor efficacy of the combination of the anti-PD-L1 antibody avelumab with platinum-based chemotherapy. Cancer Research. 79(13_Supplement). 2269–2269. 8 indexed citations

3.

Sim, Geok Choo, Chengwen Liu, Ena Wang, et al.. (2016). IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation. Cancer Immunology Research. 4(11). 983–994. 36 indexed citations

4.

Sim, Geok Choo, Sheng Wu, Lei Jin, Patrick Hwu, & Laszlo Radvanyi. (2016). Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2. Oncotarget. 7(24). 36074–36091. 11 indexed citations

5.

Tseng, William W., Shruti Malu, Minying Zhang, et al.. (2015). Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma. Sarcoma. 2015. 1–9. 53 indexed citations

6.

Khoury, Mitri K., Geok Choo Sim, Michiko Harao, et al.. (2015). Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management. BMJ Case Reports. 2015. bcr2015211218–bcr2015211218. 8 indexed citations

7.

Sim, Geok Choo, Jessica Chacon, Cara Haymaker, et al.. (2014). Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development. BioDrugs. 28(5). 421–437. 19 indexed citations

8.

Sim, Geok Choo & Laszlo Radvanyi. (2014). The IL-2 cytokine family in cancer immunotherapy. Cytokine & Growth Factor Reviews. 25(4). 377–390. 215 indexed citations

9.

Sim, Geok Choo, Natalia Martín‐Orozco, Lei Jin, et al.. (2013). IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients. Journal of Clinical Investigation. 124(1). 99–110. 186 indexed citations

10.

Radhakrishnan, Ammu Kutty, Geok Choo Sim, & Soon Keng Cheong. (2012). Comparing the Ability of Freshly Generated and Cryopreserved Dendritic Cell Vaccines to Inhibit Growth of Breast Cancer in a Mouse Model. SHILAP Revista de lepidopterología. 1(5). 239–246. 8 indexed citations

11.

Paschen, Annette, Antje Sucker, Iris Moll, et al.. (2009). Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B. Clinical Cancer Research. 15(16). 5208–5215. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact